Literature DB >> 22026334

Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection.

Leila Ksiaa Cheikh Rouhou1, Yousr Lakhoua Gorgi, Hajer Aounallah Skhiri, Houda Aouadi, Salwa Jendoubi Ayed, Imen Sfar, Khaled Ayed, Taieb Ben Abdallah.   

Abstract

INTRODUCTION: Our aim was to investigate the possibility of a significant relationship between chemokines and chemokine receptor genes polymorphisms and the spontaneous clearance or the persistence of HCV infection.
METHODS: A total of 96 hemodialysis (HD) patients infected with HCV were classified into two groups: G1 included 73 patients with persistently positive HCV-RNA and G2 included 23 HD patients who have spontaneously eliminated the virus. The control group consisted of 170 healthy blood donors. All subjects were genotyped for CCR5 ?32, CCR5 (-59029) A/G, CCR2 (64Ile) and MCP-1(-2518) A/G gene polymorphisms.
RESULTS: Our results showed a statistically significant increased frequencies of the CCR2 (64Ile) and the (-59029) CCR5 A alleles in patients infected with HCV (22.1% and 35.9%) compared to G1 (24.3% and 40.6%) and compared to controls (14.4% and 20%). We also observed a lower frequency of the MCP-1 G allele and a greater frequency of the CCR5?32 variant in G2 (15.2% and 6.5%) compared to G1 (22.6% and 1.4%) that was not statistically significant. However, adjustment for known covariates (age, gender and HCV genotypes) didn't confirm the results of univariate analysis.
CONCLUSION: In conclusion, our study suggests a possible role for some of the studied chemokines polymorphisms in the spontaneous clearance or persistence of HCV infection in Tunisian population. These results should be further investigated by a prospective cohort studies and large population-based studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22026334     DOI: 10.4314/ajnt.v4i3.71023

Source DB:  PubMed          Journal:  Arab J Nephrol Transplant


  6 in total

1.  Genetic variants in chemokine CC subfamily genes influence hepatitis C virus viral clearance.

Authors:  Yinan Yao; Ming Yue; Feng Zang; Mei Liu; Haozhi Fan; Lingyun Zhuo; Jingjing Wu; Xueshan Xia; Yue Feng; Peng Huang; Rongbin Yu
Journal:  J Hum Genet       Date:  2018-04-27       Impact factor: 3.172

Review 2.  Association between MCP-1 2518 A>G gene polymorphism and chronic kidney disease.

Authors:  Song Mao; Liangxia Wu
Journal:  Int Urol Nephrol       Date:  2018-08-14       Impact factor: 2.370

3.  A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients.

Authors:  Moataza H Omran; Mahmoud Khamis; Nada Nasr; Ahmed A Massoud; Samar S Youssef; Noha G Bader El Din; Reham M Dawood; Khaled Atef; Rehab I Moustafa; Wael Nabil; Ashraf A Tabll; Mostafa K El Awady
Journal:  Hepat Mon       Date:  2013-12-19       Impact factor: 0.660

4.  Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients.

Authors:  Abdulkerim Yilmaz; Hakan Alagozlu; Ozturk Ozdemir; Sema Arici
Journal:  Hepat Mon       Date:  2014-07-01       Impact factor: 0.660

5.  CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users.

Authors:  Kristi Huik; Radko Avi; Andrew Carrillo; Nathan Harper; Merit Pauskar; Maarja Sadam; Tõnis Karki; Tõnu Krispin; Ulvi-Kaire Kongo; Tatiana Jermilova; Kristi Rüütel; Ave Talu; Katri Abel-Ollo; Anneli Uusküla; Sunil K Ahuja; Weijing He; Irja Lutsar
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

6.  Hepatitis C in Tunisia from 1991 to 2019: A systematic review.

Authors:  Marwa Khedhiri; Hatem Triki; Henda Triki
Journal:  Tunis Med       Date:  2021-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.